Location History:
- Covina, CA (US) (2008 - 2021)
- Los Angeles, CA (US) (2022 - 2023)
Company Filing History:
10 out of 1,636 
2 out of 2 Years Active: 2008-2025
Title: Peisheng Hu: Innovator in Cancer Therapy
Introduction
Peisheng Hu is a prominent inventor based in Covina, California, known for his significant contributions to cancer therapy. With a total of 12 patents to his name, he has made remarkable advancements in the field of immunology and targeted therapies.
Latest Patents
Among his latest patents, Hu has developed humanized anti-nuclear antibodies aimed at targeting necrosis in cancer therapy. These humanized monoclonal antibodies exhibit enhanced binding affinity and tumor uptake, with site-directed mutants of H-CDR3 showing up to an 8-fold improvement in affinity compared to their non-humanized counterparts. Additionally, he has worked on Lym-1 and Lym-2 antibody compositions and improved chimeric antigen receptor (CAR) constructs. These innovations include antibodies and CAR cells that comprise the antigen binding domains of these antibodies, along with methods for producing and utilizing them in cancer detection and treatment.
Career Highlights
Peisheng Hu has held positions at notable institutions such as the University of Southern California and Cancer Therapeutics Laboratories, Inc. His work has been pivotal in advancing therapeutic strategies for cancer treatment.
Collaborations
Throughout his career, Hu has collaborated with esteemed colleagues, including Alan L Epstein and Jiali Li, contributing to the development of innovative cancer therapies.
Conclusion
Peisheng Hu's work in the field of cancer therapy exemplifies the impact of innovative thinking and research in medicine. His patents and collaborations continue to pave the way for advancements in targeted cancer treatments.